In comparison with group EE, the IL-6, TNF-α, IL-1β, and IL-18 levels were reduced after AF treatment in a dose-dependent mode, whereas this result was reduced by LY294002 co-treatment. The gene discussed is IL6; the disease is atrial fibrillation.